Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Menlo Therapeutics, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Menlo Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Menlo Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is MNLO. The reporting company's CIK number is 1566044.
The total value of stock buying since 2005 is $16,205,012.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-25||Venbio Global Strategic Fund Ii L.p. (10% Owner)||Buy||265,000||17.00||4,505,000|
|2018-01-25||Remeditex Ventures Llc (10% Owner)||Buy||100,000||17.00||1,700,000|
|2018-01-25||Vivo Capital Fund Viii, L.p. (10% Owner)||Buy||294,118||17.00||5,000,006|
|2018-01-25||Cha Albert (Director)||Buy||294,118||17.00||5,000,006|
Insider trading activities including stock purchases, stock sales, and option exercises of MNLO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Menlo Therapeutics, Inc. (symbol MNLO, CIK number 1566044) see the Securities and Exchange Commission (SEC) website.